The global market for high content screening (HCS) market is poised for substantial growth, with an anticipated valuation reaching USD 1.6 billion in 2022 and projected to expand at a promising compound annual growth rate (CAGR) of 5.8%. This growth trajectory underscores the increasing adoption of HCS technologies in drug discovery, biological research, and pharmaceutical …
Continue reading “High Content Screening Market to Reach USD 3 Billion in 2022 at a 5.8% of CAGR”